Why Biophytis (BPTS) Shares Are Sky-Rocketing
Portfolio Pulse from Erica Kollmann
Biophytis SA (NASDAQ:BPTS) shares are trading higher after the company and Skyepharma announced a partnership for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19. The partnership aims to obtain a marketing authorization for the treatment. The company's shares are up on heavy trading volume, with more than 50 million shares traded compared to the 100-day average of just over 446 thousand shares.
September 25, 2023 | 3:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biophytis' partnership with Skyepharma for the production of Sarconeos (BIO101) for severe Covid-19 has led to a surge in its stock price.
The partnership with Skyepharma for the production of Sarconeos (BIO101) is a significant development for Biophytis. This has led to increased investor interest, resulting in a surge in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100